Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells. Mol Pharm. 2013 Oct 07; 10(10):3922-33.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.